Bloomberg breaks AACR embargo on basal cell cancer study
From the American Association for Cancer Research (AACR) this morning:
Due to an embargo break by Bloomberg News, the embargo on the paper “New Inhibitor Prevented Lesions, Reduced Tumor Size in Basal Cell Cancer,” (view the abstract) which had been previously set at 10:00 a.m. on Saturday April 2, 2011, is released. Reporters and editors planning to do the story can release their items at this time.
The study is being released at the AACR’s meeting in Orlando, which starts tomorrow. Here’s a Bloomberg story on it, although the story has a time stamp after the embargo was lifted, so it’s unclear which story broke the embargo.
I’ve asked AACR whether there will be any sanctions in this case, and will update with anything I hear back. Update,12:45 p.m. Eastern, 4/1/11: AACR tells me
Bloomberg let us know about their mistake right away. We do not intend to take further action.
Thanks to a number of people who sent me this. It was in my inbox, but would have gotten lost without those tips.
